ALSERES PHARMACEUTICALS INC /DE — Form D/A
ALSERES PHARMACEUTICALS INC /DE of HOPKINTON, MA, a company, filed a Form D amendment with the SEC on 2009-08-21. The offering totals $5.0M, of which $3.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-08-21
- Form: D/A
- Accession: 0001470418-09-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $3.9M
- Remaining: $1.1M
- Investors: 1
- Date of first sale: 2009-03-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-09478-4B
Issuer
- Name: ALSERES PHARMACEUTICALS INC /DE
- CIK: 0000094784
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 239 SOUTH STREET, HOPKINTON, MA, 01748
- Phone: 508-497-2360
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Henry Brem | Director | Hopkinton, MA |
| Robert Langer | Director | Pittsburgh, PA |
| Mark Pykett | Executive Officer | Wakefield, MA |
| Peter G Savas | Director | Boston, MA |
| Peter G Savas | Executive Officer | Boston, MA |
| Michael J Mullen | Director | Bedford, MA |
| John T Preston | Director | Boston, MA |
| Robert E Langer | Director | Durham, NC |
| Henry LS Brem | Director | Hopkinton, MA |
| Mark G Pykett | Executive Officer | Hopkinton, MA |
| Kenneth L Rice, Jr. | Executive Officer | Hopkinton, MA |
| William LS Guinness | Director | Hopkinton, MA |
| GARY E FRASHIER | Director | BURNABY, A1 |
Other filings by this issuer (2)
More